Healthequity Stock Price Patterns
| HQY Stock | USD 83.57 0.72 0.87% |
Momentum 34
Sell Stretched
Oversold | Overbought |
Using HealthEquity hype-based prediction, you can estimate the value of HealthEquity from the perspective of HealthEquity response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in HealthEquity to buy its stock at a price that has no basis in reality. In that case, they are not buying HealthEquity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
HealthEquity after-hype prediction price | USD 83.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
HealthEquity | Build AI portfolio with HealthEquity Stock |
HealthEquity After-Hype Price Density Analysis
As far as predicting the price of HealthEquity at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in HealthEquity or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of HealthEquity, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
HealthEquity Estimiated After-Hype Price Volatility
In the context of predicting HealthEquity's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on HealthEquity's historical news coverage. HealthEquity's after-hype downside and upside margins for the prediction period are 81.30 and 85.84, respectively. We have considered HealthEquity's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
HealthEquity is very steady at this time. Analysis and calculation of next after-hype price of HealthEquity is based on 3 months time horizon.
HealthEquity Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as HealthEquity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HealthEquity backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with HealthEquity, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.18 | 2.27 | 0.00 | 0.24 | 0 Events / Month | 4 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
83.57 | 83.57 | 0.00 |
|
HealthEquity Hype Timeline
On the 29th of January HealthEquity is traded for 83.57. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.24. HealthEquity is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.18%. %. The volatility of related hype on HealthEquity is about 171.54%, with the expected price after the next announcement by competition of 83.81. About 98.0% of the company shares are owned by institutional investors. The book value of HealthEquity was currently reported as 24.93. The company has Price/Earnings To Growth (PEG) ratio of 0.74. HealthEquity had not issued any dividends in recent years. Considering the 90-day investment horizon the next projected press release will be in a few days. Check out HealthEquity Basic Forecasting Models to cross-verify your projections.HealthEquity Related Hype Analysis
Having access to credible news sources related to HealthEquity's direct competition is more important than ever and may enhance your ability to predict HealthEquity's future price movements. Getting to know how HealthEquity's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how HealthEquity may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GMED | Globus Medical | (2.17) | 12 per month | 0.87 | 0.13 | 3.67 | (2.31) | 38.89 | |
| MOH | Molina Healthcare | 5.44 | 12 per month | 2.85 | 0.06 | 3.97 | (4.52) | 13.66 | |
| PEN | Penumbra | 9.25 | 7 per month | 0.99 | 0.23 | 4.14 | (1.94) | 23.11 | |
| BTSG | BrightSpring Health Services | 0.00 | 0 per month | 1.90 | 0.12 | 2.99 | (3.49) | 9.60 | |
| BIO | Bio Rad Laboratories | 0.83 | 6 per month | 0.00 | (0.13) | 4.31 | (2.90) | 8.43 | |
| DVA | DaVita HealthCare Partners | (1.55) | 11 per month | 0.00 | (0.20) | 1.90 | (3.23) | 9.36 | |
| HSIC | Henry Schein | 0.83 | 10 per month | 1.23 | 0.1 | 2.43 | (2.33) | 13.60 | |
| CORT | Corcept Therapeutics Incorporated | 1.84 | 2 per month | 0.00 | (0.06) | 6.49 | (7.08) | 58.23 | |
| HIMS | Hims Hers Health | (2.56) | 13 per month | 0.00 | (0.20) | 4.19 | (5.66) | 15.28 |
HealthEquity Additional Predictive Modules
Most predictive techniques to examine HealthEquity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for HealthEquity using various technical indicators. When you analyze HealthEquity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About HealthEquity Predictive Indicators
The successful prediction of HealthEquity stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as HealthEquity, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of HealthEquity based on analysis of HealthEquity hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to HealthEquity's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to HealthEquity's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.